Criterion | Sensitivity | 95% CI | Specificity | 95% CI |
---|---|---|---|---|
Cut-off score for serum Hsp90-beta for differentiating lung cancer patient from control individuals | ||||
> =0.608 | 100.00 | 96.6–100.0 | 0.00 | 0.0–7.1 |
> 0.888 | 92.52 | 85.8–96.7 | 60.00 | 45.2–73.6 |
> 0.978 | 92.52 | 85.8–96.7 | 74.00 | 59.7–85.4 |
> 1.228 * | 84.11 | 75.8–90.5 | 86.00 | 73.3–94.2 |
> 1.468 | 8.41 | 3.9–15.4 | 86.00 | 73.3–94.2 |
> 1.689 | 0.00 | 0.0–3.4 | 96.00 | 86.3–99.5 |
> 1.752 | 0.00 | 0.0–3.4 | 100.00 | 92.9–100.0 |
Cut-off score for MPE Hsp90-beta for differentiating lung cancer patient from control individuals | ||||
> =1.048 | 100.00 | 96.6–100.0 | 0.00 | 0.0–7.1 |
> 1.188 | 97.20 | 92.0–99.4 | 38.00 | 24.7–52.8 |
> 1.286 | 93.46 | 87.0–97.3 | 71.00 | 57.5–83.8 |
> 1.659 * | 93.46 | 87.0–97.3 | 79.00 | 71.3–90.2 |
> 1.786 | 50.47 | 40.6–60.3 | 86.00 | 73.3–94.2 |
> 1.988 | 5.61 | 2.1–11.8 | 90.00 | 78.2–96.7 |
> 2.058 | 0.93 | 0.02–5.1 | 94.00 | 83.5–98.7 |